Saturday, June 13, 2026
🇺🇸 FDA

pharma · Nasopharyngeal Carcinoma · Hepatocellular Carcinoma

Chinese Academy of

Xiyuan Hospital of China Academy of Chinese Medical Sciences

Chinese Academy of clinical programs — 1328 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
China, TAIZHOU, CN HQ
170 Employees
NMPA registrant Type
Company details
Status
Public
HQ
China, TAIZHOU, CN
Employees
170
Programs
1328
Drugs
711
Patents
335
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Programs

Chinese Academy of projects

1,328 ClinicalTrials.gov programs sponsored by Chinese Academy of.

Chinese Academy of has 1,328 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

1,328 programs

Clinical programs

Page 4 of 28

  1. Ventoclax

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    AML (Acute Myelogenous Leukemia)

    phase 3 small molecule active

    1 trial

  2. Venues-P Valve

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pulmonary Regurgitation

    phase 3 other active

    1 trial

  3. Verum acupuncture

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colorectal Cancer

    phase 3 other active

    1 trial

  4. Vincristine Sulfate Liposome

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Adult Acute Lymphoblastic Leukemia

    phase 3 small molecule active

    1 trial

  5. Wumeiwan Jiawei Fang

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Dry Eye Syndromes

    phase 3 small molecule active

    1 trial

  6. Xiang-Sha-Liu-Jun-Zi-Tang

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Irritable Bowel Syndrome

    phase 3 small molecule active

    1 trial

  7. YiQiFang

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cancer

    phase 3 small molecule completed

    2 trials

  8. Yinhu Qingwen Granula

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19

    phase 3 small molecule on hold

    1 trial

  9. [2025]372-001

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Ischemic Stroke

    phase 3 small molecule active

    1 trial

  10. a compound glutamine capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Mucositis

    phase 3 small molecule active

    1 trial

  11. a compound glutamine capsule/a compound glutamine capsule simulated placebo

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Mucositis

    phase 3 small molecule active

    1 trial

  12. a patient self-reporting applet

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cancer Pain

    phase 3 other active

    1 trial

  13. avatrombopag

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Thrombocytopenia

    phase 3 small molecule active

    1 trial

  14. behavior intervention and male circumcision

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    HIV

    phase 3 other active

    1 trial

  15. bevacizumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Disease Free Survival

    phase 3 small molecule active

    1 trial

  16. cART(TDF/AZT+3TC+LPV/r)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute HIV Infection

    phase 3 small molecule active

    1 trial

  17. chemotherapy and SHR-1316(Adebrelimab) comnined with surgery or radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Limited Stage Small Cell Lung Cancer

    phase 3 other active

    1 trial

  18. cisplatin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Oral Cavity

    phase 3 small molecule completed

    1 trial

  19. cisplatin i.p.

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Epithelial Carcinoma, Ovarian

    phase 3 small molecule active

    1 trial

  20. clopidogrel and aspirin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Atherosclerosis

    phase 3 small molecule active

    1 trial

  21. daclatasvir

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis C

    phase 3 small molecule completed

    1 trial

  22. desiccated thyroid extract (DTE)+levothyroxine (L-T4)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Intermediate-to-High Risk Differentiated Thyroid Cancer

    phase 3 small molecule active

    1 trial

  23. folic acid

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colorectal Neoplasms

    phase 3 small molecule active

    1 trial

  24. gemcitabine and cisplatin (Induction chemotherapy)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  25. glutamine combined with thalidomide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Mucositis Oral

    phase 3 small molecule completed

    1 trial

  26. golidocitinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Peripheral T Cell Lymphoma

    phase 3 small molecule active

    1 trial

  27. internal mammary nodal irradiation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Breast Cancer

    phase 3 other active

    1 trial

  28. mCapOX plus Cetuximab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colorectal Cancer (CRC)

    phase 3 small molecule active

    1 trial

  29. misoprostol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Labor Induction

    phase 3 small molecule completed

    1 trial

  30. mitomycin C-based hyperthermic intraperitoneal chemotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    phase 3 other active

    1 trial

  31. mosapride citrate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Constipation

    phase 3 small molecule completed

    1 trial

  32. neoadjuvant chemotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Epithelial Ovarian Cancer

    phase 3 small molecule active

    1 trial

  33. novel stent

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Esophageal Cancer

    phase 3 other active

    1 trial

  34. patients were assigned to receive TNT or iTNT management

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rectal Cancer

    phase 3 small molecule active

    1 trial

  35. poliovirus vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Poliomyelitis

    phase 3 mab completed

    1 trial

  36. pralatrexate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Refractory Peripheral T-Cell Lymphoma

    phase 3 small molecule completed

    1 trial

  37. preoperative short-course radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rectal Neoplasms

    phase 3 other terminated

    1 trial

  38. recombinant human thrombopoietin (rhTPO); dexamethasone

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Purpura

    phase 3 small molecule completed

    1 trial

  39. recombinant human thrombopoietin (rhTPO); rituximab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Purpura

    phase 3 small molecule terminated

    1 trial

  40. rhTPO in combination with Rituximab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Purpura

    phase 3 small molecule completed

    1 trial

  41. rituximab; recombinant human thrombopoietin (rhTPO)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Purpura

    phase 3 small molecule completed

    1 trial

  42. shenfu injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Septic Shock

    phase 3 small molecule active

    1 trial

  43. tacrolimus capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lupus Nephritis

    phase 3 small molecule terminated

    1 trial

  44. toripalimab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Esophageal Cancer

    phase 3 small molecule active

    1 trial

  45. urapidil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Stroke, Acute

    phase 3 small molecule completed

    1 trial

  46. 0.2mg group

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Opioid Dependence

    phase 2 small molecule active

    1 trial

  47. 16mg，KB

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sepsis

    phase 2 small molecule active

    1 trial

  48. 1μg/ml ESAT6-CFP10 and tuberculin purified protein derivative

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Tuberculosis

    phase 2 mab completed

    1 trial

Frequently asked questions

How many clinical projects does Chinese Academy of have?

1,328 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.